|
07/11/2024
|
09:59
|
Form 8.5 (EPT/NON-RI) - Tissue Regenix Group PLC
|
RNS
|
|
06/11/2024
|
13:37
|
Form 8.3 - Tissue Regenix Group PLC
|
RNS
|
|
06/11/2024
|
08:52
|
Form 8.5 (EPT/NON-RI)
|
RNS
|
|
05/11/2024
|
14:24
|
Form 8.3 - Tissue Regenix Group PLC
|
RNS
|
|
05/11/2024
|
11:32
|
Form 8.5 (EPT/NON-RI)
|
RNS
|
|
04/11/2024
|
16:36
|
Response to media speculation
|
RNS
|
|
10/09/2024
|
07:00
|
Interim results for the six months ended 30 June
|
RNS
|
|
18/07/2024
|
15:52
|
Grant of share options
|
RNS
|
|
16/07/2024
|
07:00
|
Half-Year Trading Update
|
RNS
|
|
03/07/2024
|
13:16
|
Holding(s) in Company
|
RNS
|
|
24/06/2024
|
16:12
|
Holding(s) in Company
|
RNS
|
|
18/06/2024
|
17:15
|
Exercise of Options, Director Dealing and TVR
|
RNS
|
|
14/06/2024
|
07:00
|
Building purchase
|
RNS
|
|
25/04/2024
|
14:27
|
Result of AGM
|
RNS
|
|
05/04/2024
|
15:52
|
Holding(s) in Company
|
RNS
|
|
19/03/2024
|
07:00
|
Final results for the year ended 31 December 2023
|
RNS
|
|
01/03/2024
|
07:00
|
Notice of Results
|
RNS
|
|
29/01/2024
|
15:02
|
Holding(s) in Company
|
RNS
|
|
25/01/2024
|
07:00
|
Trading update for 2023
|
RNS
|
|
23/01/2024
|
17:24
|
2023 LTIP Grant
|
RNS
|
|
22/11/2023
|
16:36
|
Holding(s) in Company
|
RNS
|
|
30/10/2023
|
07:00
|
HPRA approval & distribution agreement in Spain
|
RNS
|
|
18/09/2023
|
10:40
|
Hardman & Co Research on Tissue Regenix (TRX): Continuing postive momentum 1H'23
|
EQS Group
|
|
15/09/2023
|
16:30
|
Director/PDMR Shareholding
|
RNS
|
|
05/09/2023
|
07:01
|
New sports medicine product launch
|
RNS
|
|
05/09/2023
|
07:00
|
Interim results
|
RNS
|
|
31/08/2023
|
13:45
|
Exercise of Options and Total Voting Rights
|
RNS
|
|
21/08/2023
|
07:00
|
Notice of interim results
|
RNS
|
|
17/07/2023
|
07:00
|
Half-Year Trading Update
|
RNS
|
|
10/07/2023
|
07:00
|
Distribution agreement for OrthoPure® XT in the UK
|
RNS
|
|
25/05/2023
|
07:00
|
Distribution agreement with Australian Allografts
|
RNS
|
|
09/05/2023
|
12:00
|
Holding(s) in Company
|
RNS
|
|
27/04/2023
|
12:35
|
Result of AGM, Share Reorganisation &TVR
|
RNS
|
|
18/04/2023
|
07:00
|
Proposed Share Reorganisation Timetable
|
RNS
|
|
05/04/2023
|
14:55
|
Hardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative
|
EQS Group
|
|
05/04/2023
|
07:00
|
CEO and CFO Share Purchases
|
RNS
|
|
30/03/2023
|
07:00
|
Holding(s) in Company
|
RNS
|
|
21/03/2023
|
07:00
|
Final results for the year ended 31 December 2022
|
RNS
|
|
06/03/2023
|
07:00
|
Notice of results and Investor presentation
|
RNS
|
|
31/01/2023
|
07:01
|
Trading update for 2022
|
RNS
|
|
31/01/2023
|
07:00
|
Change of Adviser
|
RNS
|
|
18/01/2023
|
10:06
|
Holding(s) in Company
|
RNS
|
|
18/01/2023
|
07:00
|
Chinese distribution agreement for OrthoPure® XT
|
RNS
|
|
14/12/2022
|
12:00
|
TRX Gold's 19-hole metallurgical testing program shows positive results
|
EQS Group
|
|
07/12/2022
|
07:00
|
Product launch in dCELL® division
|
RNS
|
|
06/12/2022
|
16:01
|
TRX Gold Corp releases strong Q4 and year-end results as company looks for a big 2023
|
EQS Group
|
|
22/11/2022
|
07:00
|
Distribution agreement - OrthoPure® XT in Germany
|
RNS
|
|
14/11/2022
|
18:05
|
Holding(s) in Company
|
RNS
|
|
07/11/2022
|
14:35
|
Holding(s) in Company
|
RNS
|
|
29/09/2022
|
10:13
|
Director/PDMR Shareholding
|
RNS
|